Please login to the form below

vildagliptin

This page shows the latest vildagliptin news and features for those working in and with pharma, biotech and healthcare.

Novartis to make 15 drugs available at $1 a month

Among the drugs to be made available under the scheme are high blood pressure medicine valsartan, tamoxifen for breast cancer and vildagliptin for diabetes.

Latest news

AZ sues to block generic saxagliptin from Mylan

world market for DPP4 inhibitors, a class which also includes Merck &Co's market-leading Januvia (sitagliptin), Novartis' Galvus (vildagliptin) and Boehringer Ingelheim/Lilly's Trajenta (linagliptin).
Pfizer still number one - just

Meanwhile, Novartis kept the pressure on with solid performances for its own new entrants, including Gilenya (fingolimod) for multiple sclerosis, cancer drugs Afinitor/Votubia (everolimus) and Tasigna (nilotinib) and Galvus (vildagliptin)
NICE turns down Afinitor for breast cancer

for leukaemia, Galvus (vildagliptin) for diabetes and blood cancer therapy Jakavi (ruxolitinib).
Novartis lifts 2013 guidance on delay to Diovan generics

Gilenya (fingolimod), Afinitor (everolimus) for breast cancer, leukaemia therapy Tasigna (nilotinib) and Galvus (vildagliptin) for diabetes just about offsetting revenue losses to generic competition of some $800m in the quarter.
Setback for AZ and BMS as Onglyza flunks cardiovascular trial

vildagliptin). The trial was set up in the wake of new US FDA guidelines in 2009 which required pharma companies to perform cardiovascular outcome studies on new diabetes drugs.

More from news
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

bmore creative hires Kush Rach as new business director

He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Graduate Scientific Editor: DOE

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Medical Writer – Very Flexible Working – Surrey: Negotiable

Account Director, Medical Education: Salary TBC

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Account Executive: Salary TBC

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Account Supervisor: Salary TBC

Entry Level Editorial Assistant – Medical Education –Buckinghams...: Highly Competitive

Scientific Director - Medical Communications - Berkshire: Excellent package on offer

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Senior Editor - Medical Communications - South East - Buckingham...: Highly competitive salary &package

Editorial Team Leader – Medical Communications – Buckinghamshire...: Salary TBC

Account Director: Salary TBC

Senior Medical Writer: Salary TBC

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Subscribe to our email news alerts

PMHub

Add my company

Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Using human insights to push healthcare communications forward: This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy: The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail: We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...